rs10808565
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000513868.6(PVT1):n.971+5875C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.315 in 152,042 control chromosomes in the GnomAD database, including 8,661 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.31 ( 8661 hom., cov: 32)
Consequence
PVT1
ENST00000513868.6 intron
ENST00000513868.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.47
Publications
5 publications found
Genes affected
PVT1 (HGNC:9709): (Pvt1 oncogene) This gene represents a long non-coding RNA locus that has been identified as a candidate oncogene. Increased copy number and overexpression of this gene are associated with many types of cancers including breast and ovarian cancers, acute myeloid leukemia and Hodgkin lymphoma. Allelic variants of this gene are also associated with end-stage renal disease attributed to type 1 diabetes. Consistent with its association with various types of cancer, transcription of this gene is regulated by the tumor suppressor p53 through a canonical p53-binding site, and it has been implicated in regulating levels of the proto-oncogene MYC to promote tumorigenesis. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.507 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PVT1 | ENST00000513868.6 | n.971+5875C>T | intron_variant | Intron 4 of 7 | 1 | |||||
| PVT1 | ENST00000653497.1 | n.218C>T | non_coding_transcript_exon_variant | Exon 1 of 7 | ||||||
| PVT1 | ENST00000665721.2 | n.1169C>T | non_coding_transcript_exon_variant | Exon 5 of 5 |
Frequencies
GnomAD3 genomes AF: 0.315 AC: 47822AN: 151924Hom.: 8647 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
47822
AN:
151924
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.315 AC: 47859AN: 152042Hom.: 8661 Cov.: 32 AF XY: 0.321 AC XY: 23824AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
47859
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
23824
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
6301
AN:
41508
American (AMR)
AF:
AC:
7884
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1304
AN:
3468
East Asian (EAS)
AF:
AC:
1132
AN:
5160
South Asian (SAS)
AF:
AC:
2139
AN:
4814
European-Finnish (FIN)
AF:
AC:
3514
AN:
10562
Middle Eastern (MID)
AF:
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24409
AN:
67950
Other (OTH)
AF:
AC:
745
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1622
3244
4867
6489
8111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1107
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.